Three Innovative Ideas Receive $10,000 Prizes in Patients | Choices | Empowerment Competition

AmgenThe Amgen Foundation and Ashoka's Changemakers today announced three winners for the Patients | Choices | Empowerment competition. Each winner will receive a $10,000 cash prize and was selected by the public for their innovative solutions that empower and elevate patients' voices to improve health outcomes.

Out of 10 finalists, the entries receiving the most votes in the Changemakers.com competition are:

1. CureTogether - Crowdsourced Patient Experience
2. Educating Tuberculosis patients for excellent results
3. SMS Now! A Life Depends on It.

In addition, selected entries may be considered for additional grants totaling up to $1 million from the Amgen Foundation.

"The Patients | Choices | Empowerment winners demonstrate that it is possible to create innovative tools and resources that empower patients and offer collaborative solutions at every stage of healthcare," said Jean Lim, president of the Amgen Foundation. "This competition has helped to build a global community of innovators who are working to ensure that patients have an active role in their personal healthcare. We look forward to reviewing the entries to identify sustainable solutions that both the Amgen Foundation and other interested funders can support."

The winning entries are crowdsourcing quantitative data to help patients make more informed choices about their healthcare; removing the stigma around tuberculosis and encouraging and supporting treatment; and utilizing the internet and mobile technology to connect volunteer blood donors with patients. All of these innovations demonstrate global solutions.

"The Patients | Choices | Empowermentcompetition uncovered ideas that help patients makedecisions with confidence and clarity,in concertwithpeople who careand can help," said Diana Wells, president of Ashoka. "We are so pleased with the online community that joined the Changemakers platform, voted, and shared their feedback on these innovative solutions. We are also incredibly thankful to our expert judges and commentators who contributed to the creation of a rich, global dialogue on the important issues that ultimately resulted in the selection of three outstanding entries."

In addition to the $10,000 cash prizes, the three Patients | Choices | Empowermentcompetition winners will be featured on Changemakers.com as innovative ideas for empowering the patient and providing avenues for informed decisions.

About Ashoka's Changemakers
Ashoka's Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other. Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social problems. Changemakers builds on Ashoka's three decade history and belief that we all have the ability to be a Changemaker. www.Changemakers.com

About the Amgen Foundation
The Amgen Foundation seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made more than $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico, and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally.

Most Popular Now

Novo Nordisk announces plans to transform its appr…

Novo Nordisk announced plans to restructure its Research & Development (R&D) organisation to accelerate the expansion and diversification of its pipeline across serious c...

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Sat...

World's largest Alzheimer's survey reveals most ad…

Amgen (NASDAQ:AMGN), Novartis and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest glob...

Imfinzi is the first immunotherapy to demonstrate …

AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi durin...

Pre-clinical success for a universal flu vaccine o…

Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Co...

Discovery could explain failed clinical trials for…

Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trial...

Global survey reveals that physicians need more in…

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make inf...

Aspirin found not to prolong healthy aging

Taking a low-dose aspirin daily does not prolong healthy living in older adults, according to findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial p...

The Lancet Respiratory Medicine publishes first Ph…

AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide...

In clinical trials, new antibody therapy controls …

Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers i...

FDA approves first treatment for advanced form of …

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squam...

Clinical gene discovery program solves 30 medical …

A table in a recently published paper tells the story of 30 families who have, sometimes after years of searching, finally received an answer about the condition that has...